Jefferies Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-41,600
Closed -$24.1M 2194
2025
Q4
$24.1M Hold
41,600
0.12% 166
2025
Q3
$20.2M Hold
41,600
0.1% 149
2025
Q2
$16.9M Hold
41,600
0.14% 114
2025
Q1
$20.7M Hold
41,600
0.18% 77
2024
Q4
$21.6M Hold
41,600
0.13% 117
2024
Q3
$25.7M Sell
41,600
-2,000
-5% -$1.18M 0.18% 69
2024
Q2
$24.1M Sell
43,600
-3,200
-7% -$1.83M 0.26% 61
2024
Q1
$27.2M Buy
46,800
+42,000
+875% +$23.6M 0.25% 61
2023
Q4
$2.55M Sell
4,800
-4,100
-46% -$1.98M 0.02% 620
2023
Q3
$4.5M Buy
+8,900
New +$4.74M 0.04% 367
2023
Q2
Sell
-119,800
Closed -$69M 2008
2023
Q1
$69M Buy
119,800
+115,200
+2,504% +$64.9M 0.56% 24
2022
Q4
$2.53M Buy
+4,600
New +$2.44M 0.02% 577

Other funds holding TMO

Jefferies Financial Group's TMO Position: Q1 2026 in Review

Jefferies Financial Group increased its Thermo Fisher Scientific (TMO) stake by 3,685% in Q1 2026, buying an estimated $29M and bringing the position to 54,886 shares worth $27M. The position accounts for 0.18% of the portfolio, ranked #87.

Jefferies Financial Group first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $48M in Q4 2022. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Jefferies Financial Group held 54,886 shares of Thermo Fisher Scientific worth $27M as of Q1 2026.
  • Jefferies Financial Group bought 53,436 Thermo Fisher Scientific shares in Q1 2026, an estimated $29M.
  • Thermo Fisher Scientific made up 0.18% of Jefferies Financial Group's portfolio in Q1 2026, its #87 holding.
  • Jefferies Financial Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Thermo Fisher Scientific position peaked at $48M in Q4 2022.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.